دورية أكاديمية
A multicenter retrospective study of patients treated in the thalamus with responsive neurostimulation.
| العنوان: | A multicenter retrospective study of patients treated in the thalamus with responsive neurostimulation. |
|---|---|
| المؤلفون: | Fields MC; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Eka O; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Schreckinger C; St. Mary's Health Care System, Athens, GA, United States., Dugan P; Department of Neurology, Langone Medical Center, New York University, New York, NY, United States., Asaad WF; Department of Neurosurgery, Warren Alpert Medical School, Brown University, Providence, RI, United States., Blum AS; Department of Neurology, Warren Alpert Medical School, Brown University, Providence, RI, United States., Bullinger K; Department of Neurology, School of Medicine, Emory University, Atlanta, GA, United States., Willie JT; Department of Neurosurgery, School of Medicine, Washington University in St Louis, St. Louis, MO, United States., Burdette DE; Department of Neurosciences, Corewell Health, Grand Rapids, MI, United States., Anderson C; Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States., Quraishi IH; Department of Neurology, School of Medicine, Yale University, New Haven, CT, United States., Gerrard J; Department of Neurosurgery, School of Medicine, Yale University, New Haven, CT, United States., Singh A; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Lee K; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Yoo JY; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Ghatan S; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Panov F; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Marcuse LV; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. |
| المصدر: | Frontiers in neurology [Front Neurol] 2023 Sep 08; Vol. 14, pp. 1202631. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation, 2010]- |
| مستخلص: | Introduction: For drug resistant epilepsy patients who are either not candidates for resective surgery or have already failed resective surgery, neuromodulation is a promising option. Neuromodulatory approaches include responsive neurostimulation (RNS), deep brain stimulation (DBS), and vagal nerve stimulation (VNS). Thalamocortical circuits are involved in both generalized and focal onset seizures. This paper explores the use of RNS in the centromedian nucleus of the thalamus (CMN) and in the anterior thalamic nucleus (ANT) of patients with drug resistant epilepsy. Methods: This is a retrospective multicenter study from seven different epilepsy centers in the United States. Patients that had unilateral or bilateral thalamic RNS leads implanted in the CMN or ANT for at least 6 months were included. Primary objectives were to describe the implant location and determine changes in the frequency of disabling seizures at 6 months, 1 year, 2 years, and > 2 years. Secondary objectives included documenting seizure free periods, anti-seizure medication regimen changes, stimulation side effects, and serious adverse events. In addition, the global clinical impression scale was completed. Results: Twelve patients had at least one lead placed in the CMN, and 13 had at least one lead placed in the ANT. The median baseline seizure frequency was 15 per month. Overall, the median seizure reduction was 33% at 6 months, 55% at 1 year, 65% at 2 years, and 74% at >2 years. Seizure free intervals of at least 3 months occurred in nine patients. Most patients (60%, 15/25) did not have a change in anti-seizure medications post RNS placement. Two serious adverse events were recorded, one related to RNS implantation. Lastly, overall functioning seemed to improve with 88% showing improvement on the global clinical impression scale. Discussion: Meaningful seizure reduction was observed in patients who suffer from drug resistant epilepsy with unilateral or bilateral RNS in either the ANT or CMN of the thalamus. Most patients remained on their pre-operative anti-seizure medication regimen. The device was well tolerated with few side effects. There were rare serious adverse events. Most patients showed an improvement in global clinical impression scores. Competing Interests: KB receives salary support from Neuropace. FP and LM are a speaker for Neuropace. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Fields, Eka, Schreckinger, Dugan, Asaad, Blum, Bullinger, Willie, Burdette, Anderson, Quraishi, Gerrard, Singh, Lee, Yoo, Ghatan, Panov and Marcuse.) |
| References: | Epilepsia. 2021 Dec;62(12):2883-2898. (PMID: 34697794) Epilepsia. 2013 Oct;54(10):1823-33. (PMID: 24032641) Epilepsia. 2006 Jul;47(7):1203-12. (PMID: 16886984) Epilepsia. 2021 Jun;62(6):1306-1317. (PMID: 33830503) Ann Clin Transl Neurol. 2020 Oct;7(10):2035-2040. (PMID: 32860345) Ann Clin Transl Neurol. 2019 Oct;6(10):2104-2109. (PMID: 31508904) Front Neurol. 2021 Apr 28;12:656585. (PMID: 33995254) Front Neurosci. 2018 Jul 31;12:474. (PMID: 30108472) Epilepsia Open. 2019 Jan 29;4(1):187-192. (PMID: 30868130) Exp Neurol. 1960 Jun;2:271-89. (PMID: 14423595) Res Publ Assoc Res Nerv Ment Dis. 1952;30:513-28. (PMID: 12983687) J Clin Neurosci. 2019 May;63:1-7. (PMID: 30827880) Epilepsia. 1995 Jan;36(1):63-71. (PMID: 8001511) Epilepsy Behav. 2022 Apr;129:108646. (PMID: 35299087) Front Hum Neurosci. 2022 Apr 12;16:876204. (PMID: 35496067) Ann Clin Transl Neurol. 2023 Jan;10(1):136-143. (PMID: 36480536) Neurology. 2013 Nov 19;81(21):1869-76. (PMID: 24142476) J Neurosurg Case Lessons. 2022 Mar 21;3(12):. (PMID: 36273865) Arch Med Res. 2000 May-Jun;31(3):304-15. (PMID: 11036182) Stereotact Funct Neurosurg. 2023;101(2):75-85. (PMID: 36731446) Epilepsia Open. 2021 Sep;6(3):611-617. (PMID: 34268893) Electroencephalogr Clin Neurophysiol. 1955 Feb;7(1):99-114. (PMID: 14353024) Neurosurgery. 2000 Aug;47(2):295-304; discussion 304-5. (PMID: 10942002) Hum Brain Mapp. 2012 Nov;33(11):2627-37. (PMID: 21932264) Arch Neurol. 1967 Mar;16(3):277-85. (PMID: 4959933) J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):339-349. (PMID: 31980515) J Neurophysiol. 1951 Nov;14(6):461-77. (PMID: 14889301) Neurosurgery. 2020 Oct 15;87(5):E578-E583. (PMID: 32023343) Brain. 2022 Oct 21;145(10):3347-3362. (PMID: 35771657) Brain Sci. 2023 Feb 14;13(2):. (PMID: 36831867) Clin Neurophysiol. 2023 Apr;148:93-94. (PMID: 36822120) J Neurol Neurosurg Psychiatry. 2022 May;93(5):491-498. (PMID: 35217517) Neurology. 2020 Sep 1;95(9):e1244-e1256. (PMID: 32690786) Front Hum Neurosci. 2022 Jul 15;16:926337. (PMID: 35911594) Epilepsy Behav. 2020 Nov;112:107354. (PMID: 32919199) Epilepsia. 2010 May;51(5):899-908. (PMID: 20331461) |
| فهرسة مساهمة: | Keywords: anterior thalamic nucleus; centromedian nucleus of thalamus; drug-resistant epilepsy (DRE); epilepsy surgery; neuromodulation; responsive neurostimulation (RNS) |
| تواريخ الأحداث: | Date Created: 20230925 Latest Revision: 20240409 |
| رمز التحديث: | 20240409 |
| مُعرف محوري في PubMed: | PMC10516547 |
| DOI: | 10.3389/fneur.2023.1202631 |
| PMID: | 37745648 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-2295 |
|---|---|
| DOI: | 10.3389/fneur.2023.1202631 |